Clinical Study of Xuanbai Chengqi Tang Therapeutic Aspiration Syndrome

CUI Ke; LIN Rong-hai; LIN Xiao-hui; CHEN Zhong-teng

doi:10.13422/j.cnki.syfix.2014080207

您当前的位置：

首页 >

文章列表页 >

Clinical Study of Xuanbai Chengqi Tang Therapeutic Aspiration Syndrome

更新时间：2024-01-04

- Clinical Study of Xuanbai Chengqi Tang Therapeutic Aspiration Syndrome
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 8, Pages: 207-209(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfix.2014080207
  CLC：
- Published：2014
- 稿件说明：
移动端阅览
CUI Ke, LIN Rong-hai, LIN Xiao-hui, et al. Clinical Study of Xuanbai Chengqi Tang Therapeutic Aspiration Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(8): 207-209.
DOI：

CUI Ke, LIN Rong-hai, LIN Xiao-hui, et al. Clinical Study of Xuanbai Chengqi Tang Therapeutic Aspiration Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(8): 207-209. DOI： 10.13422/j.cnki.syfix.2014080207.

摘要

目的：评价宣白承气汤治疗误吸综合征的临床疗效。方法：采用随机、对照研究方法，设置宣白承气汤组和对照组，两组患者组内又分为机械通气组（MV）和非机械通气（NO-MV）两个亚组。对照组，采用西医常规治疗手段；宣白承气汤组，在西医常规治疗基础上，加用宣白承气汤口服。①观察记录内容包括：治疗前及治疗5 d后氧合指数（PaO2/FiO2）、体温、白细胞计数、C反应蛋白（CRP）等。②疗效评价：对患者2周后的肺部情况进行评价。结果：① 经5 d治疗后，宣白承气汤组与对照组进行亚组之间比较，无论是MV或是NO-MV两亚组间氧合指数、体温差异有统计学意义（P<0.05）、而体温、白细胞计数方面，两组仅在NO-MV亚组有统计学差异（P<0.05）。②治疗2周后，评价两组患者肺损伤的预后，二者疗效差异有统计学意义（P<0.05）。结论：西医常规治疗基础上配合宣白承气汤有助于减轻患者的肺部损伤，提高治疗效果，其机制可能与减轻全身炎症反应有关。

Abstract

Objective: To evaluate the clinical effect of Xuanbai Chengqi tang therapeutic aspiration syndrome. Method: A randomized

controlled study methods

seting Xuanbai Chengqi tang group and the control group. Each group is divided into two subgroups of patients group mechanical ventilation (MV) and non-mechanical ventilation (NO-MV). Control group

the use of conventional Western medicine treatment;Xuanbai Chengqi tang group

on the basis of conventional Western medicine

Plus Xuanbai Chengqi tang orally. ① Observations content include:before treatment and after 5 days oxygenation index (PaO2/FiO2)

body temperature

white blood cell count

C-reactive protein (CRP) and so on. ② Therapeutic evaluation:after 2 weeks of treatment

patients were evaluated prognosis of lung injury. Result: ① After 5 days treatment

Xuanbai Chengqi tang group comparison control group between subgroups

Whether NO-MV or MV two subgroups oxygenation index

temperature difference was statistically significant (P<0.05) and but body temperature

white blood cell count

the two groups only in the NO-MV subgroups were significantly different (P<0.05). ② After 2 weeks of treatment

two groups patients were evaluated prognosis of lung injury

there are statistically significant difference in clinical effect (P<0.05). Conclusion: Based on the conventional Western medicine treatment

with the Prescription of Xuanbai Chengqi tang helps reduce the patient's lung damage

improve the therapeutic effect

its mechanism may reduce the systemic inflammatory response.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Research Progress of Shengjiangsan in Treating Systemic Inflammatory Response Syndrome

Protective Effect of Artemisinin on Mice with Systemic Inflammatory Response Syndrome

Protective Effect of Phenolic Compound of Osmundae Rhizoma on Systemic Inflammatory Response Syndrome in Mice

Protective Effect of Different Extracts of on Endotoxin Induced Systemic Inflammatory Response Syndrome in Mice

Related Author

Ji-hong FENG

Yu HAN

Shan-shan ZHANG

Ming-da BI

Yun-pu QIN

Qing YANG

Hong ZHANG

Ying CHEN

Related Institution

Tianjin University of Traditional Chinese Medicine（TCM）

The Second Affiliated Hospital of Tianjin University of TCM

Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences

Anhui University of Chinese Medicine

Research Center of Artemisinin, China Academy of Chinese Medical Sciences

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰